The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing

The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing

John B Christoforidis,1 Jillian Wang,2 Angela Jiang,2 James Willard,5 Cedric Pratt,2 Mahmoud Abdel-Rasoul,3 Sashwati Roy,4 Heather Powell51Department of Ophthalmology and Vision Science, College of Medicine, The University of Arizona, Tucson, AZ, USA; 2Department of Ophthalmology, College of Medicin...

Full description

Bibliographic Details
Main Authors:	Christoforidis JB, Wang J, Jiang A, Willard J, Pratt C, Abdel-Rasoul M, Roy S, Powell HM
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-01-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/the-effect-of-intravitreal-bevacizumab-and-ranibizumab-on-cutaneous-te-a12059

Similar Items

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity
by: Osman Melih Ceylan, et al.

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity
by: Muhammet Kazim Erol, et al.
Published: (2015-12-01)

Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model
by: Christoforidis, John Byron, et al.
Published: (2017)

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
by: Antonopoulos C, et al.
Published: (2011-11-01)

Transfer of single dose of intravitreal injection of ranibizumab and bevacizumab into milk of sheep
by: Tugba Cakmak Argun, et al.
Published: (2017-07-01)

The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model
by: Christoforidis J, et al.
Published: (2012-01-01)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
by: Pessoa B, et al.
Published: (2021-01-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye
by: Mohammadreza Peyman, et al.
Published: (2019-03-01)

Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
by: Ramy M Hanna, et al.
Published: (2020-02-01)

Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
by: Alex Yuan, et al.
Published: (2014-02-01)

Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizuma
by: Kanwal Zareen Abbasi
Published: (2016-03-01)

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
by: Suthasinee Kumluang, et al.
Published: (2019-03-01)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
by: Partha Biswas, et al.
Published: (2011-01-01)

Lasting Controversy on Ranibizumab and Bevacizumab
by: Lihui Zou, Huiying Lai, Qi Zhou, Fei Xiao
Published: (2011-01-01)

Intravitreal bevacizumab
by: Bakulesh M Khamar
Published: (2018-01-01)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
by: Pukhraj Rishi, et al.
Published: (2011-01-01)

The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs
by: Berker Bakbak, et al.
Published: (2016-01-01)

Intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
by: Amr Abdel-Fattah Ali Gab-Alla
Published: (2015-01-01)

Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy
by: Miguel Hage Amaro, et al.
Published: (2012-08-01)

Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis.
by: Wei Wang, et al.
Published: (2014-01-01)

Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration Ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade
by: Aaron Brock Roller, et al.
Published: (2009-10-01)

Diabetic papillopathy treated with intravitreal ranibizumab
by: Yildirim M, et al.
Published: (2017-03-01)

Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: A retrospective review
by: Francis Char DeCroos, et al.
Published: (2014-01-01)

Stem Cells for Cutaneous Wound Healing
by: Giles T. S. Kirby, et al.
Published: (2015-01-01)

Delayed Corneal Epithelial Healing after Intravitreal Bevacizumab: A Clinical and Experimental Study
by: Gustavo A Colombres, et al.
Published: (2011-01-01)

Effect of astaxanthin on cutaneous wound healing
by: Meephansan J, et al.
Published: (2017-07-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

Development of tensile strength methodology for murine skin wound healing
by: Anuj Bellare, et al.
Published: (2018-01-01)

Intravitreal ranibizumab as adjuvant treatment for neovascular glaucoma
by: Flavia Gazze Ticly, et al.
Published: (2013-04-01)

Successful Resolution of Preretinal Haemorrhage with Intravitreal Ranibizumab
by: Baharuddin Noorlaila, et al.
Published: (2016-01-01)

Single intravitreal ranibizumab for myopic choroidal neovascularization
by: Shatriah I, et al.
Published: (2011-08-01)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
by: Xiu-Juan Li, et al.
Published: (2016-01-01)

Renal damage associated to intravitreal administration of ranibizumab
by: Enrique Morales, et al.
Published: (2017-11-01)

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
by: Carlos Menezes, et al.
Published: (2015-06-01)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
by: Chiung-Yi Chiu, et al.
Published: (2021-01-01)

Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection
by: Lavnish Joshi, et al.
Published: (2012-09-01)

Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
by: Marey HM, et al.
Published: (2011-06-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Nikunj J Shah, et al.
Published: (2011-01-01)